Ami M. Kabadi

3.9k total citations · 2 hit papers
15 papers, 2.9k citations indexed

About

Ami M. Kabadi is a scholar working on Molecular Biology, Genetics and Aging. According to data from OpenAlex, Ami M. Kabadi has authored 15 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Aging. Recurrent topics in Ami M. Kabadi's work include CRISPR and Genetic Engineering (12 papers), Pluripotent Stem Cells Research (5 papers) and Virus-based gene therapy research (3 papers). Ami M. Kabadi is often cited by papers focused on CRISPR and Genetic Engineering (12 papers), Pluripotent Stem Cells Research (5 papers) and Virus-based gene therapy research (3 papers). Ami M. Kabadi collaborates with scholars based in United States, France and Saudi Arabia. Ami M. Kabadi's co-authors include Charles A. Gersbach, Pratiksha I. Thakore, David G. Ousterout, Timothy E. Reddy, Gregory E. Crawford, Kam W. Leong, Pablo Pérez‐Piñera, Lingyun Song, Alexias Safi and Anthony D’Ippolito and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nature Methods.

In The Last Decade

Ami M. Kabadi

14 papers receiving 2.8k citations

Hit Papers

RNA-guided gene activation by CRISPR-Cas9–based transcrip... 2013 2026 2017 2021 2013 2015 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RNA-guided gene activation by CRISPR-Cas9–based transcription factors
    2013 1.0k citations Pablo Pérez‐Piñera, D. Dewran Koçak et al. Nature Methods profile →
  2. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements
    2015 690 citations Pratiksha I. Thakore, Anthony D’Ippolito et al. Nature Methods profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ami M. Kabadi United States 12 2.7k 605 226 201 188 15 2.9k
Zairan Liu United States 5 2.6k 1.0× 438 0.7× 257 1.1× 207 1.0× 242 1.3× 5 2.8k
Samira Kiani United States 19 3.2k 1.2× 620 1.0× 227 1.0× 193 1.0× 244 1.3× 32 3.6k
Marcelle Tuttle United States 6 2.1k 0.8× 358 0.6× 209 0.9× 143 0.7× 161 0.9× 13 2.2k
Isaac B. Hilton United States 17 2.6k 1.0× 548 0.9× 178 0.8× 205 1.0× 261 1.4× 25 3.0k
Kendell Clement United States 23 2.8k 1.0× 680 1.1× 105 0.5× 121 0.6× 192 1.0× 41 3.0k
Nicolas Wyvekens United States 9 2.5k 0.9× 519 0.9× 204 0.9× 355 1.8× 288 1.5× 11 2.6k
Sarah J. Hinkley United States 6 2.4k 0.9× 706 1.2× 132 0.6× 156 0.8× 340 1.8× 8 2.6k
Suhani Vora United States 5 1.6k 0.6× 247 0.4× 155 0.7× 110 0.5× 113 0.6× 6 1.7k
Daniel P. Dever United States 17 2.4k 0.9× 947 1.6× 118 0.5× 251 1.2× 93 0.5× 28 2.9k
Michael C. Bassik United States 2 1.8k 0.6× 286 0.5× 128 0.6× 102 0.5× 105 0.6× 2 1.9k

Countries citing papers authored by Ami M. Kabadi

Since Specialization
Citations

This map shows the geographic impact of Ami M. Kabadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami M. Kabadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami M. Kabadi more than expected).

Fields of papers citing papers by Ami M. Kabadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ami M. Kabadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami M. Kabadi. The network helps show where Ami M. Kabadi may publish in the future.

Co-authorship network of co-authors of Ami M. Kabadi

This figure shows the co-authorship network connecting the top 25 collaborators of Ami M. Kabadi. A scholar is included among the top collaborators of Ami M. Kabadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ami M. Kabadi. Ami M. Kabadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kabadi, Ami M., Maria Katherine Mejía‐Guerra, John D. Graef, et al.. (2023). AAV-based CRISPR-Cas9 genome editing: Challenges and engineering opportunities. Current Opinion in Biomedical Engineering. 29. 100517–100517. 7 indexed citations
2.
Kabadi, Ami M., Rhianna E. Lee, Ian C. McDowell, et al.. (2021). Epigenome editing of the CFTR-locus for treatment of cystic fibrosis. Journal of Cystic Fibrosis. 21(1). 164–171. 12 indexed citations
3.
Kabadi, Ami M., Eoin McDonnell, Christopher L. Frank, & Lauren Drowley. (2020). Applications of Functional Genomics for Drug Discovery. SLAS DISCOVERY. 25(8). 823–842. 6 indexed citations
4.
Song, Lingyun, Ami M. Kabadi, Jennifer B. Kwon, et al.. (2017). Incomplete MyoD-induced transdifferentiation is associated with chromatin remodeling deficiencies. Nucleic Acids Research. 45(20). 11684–11699. 24 indexed citations
5.
Thakore, Pratiksha I., Anthony D’Ippolito, Lingyun Song, et al.. (2015). Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nature Methods. 12(12). 1143–1149. 690 indexed citations breakdown →
6.
Ousterout, David G., Ami M. Kabadi, Pratiksha I. Thakore, et al.. (2015). Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nature Communications. 6(1). 6244–6244. 338 indexed citations
7.
Thakore, Pratiksha I., Anthony D’Ippolito, Lingyun Song, et al.. (2015). 485. Targeted Epigenome Editing by CRISPR/Cas9-Based Repressors for Silencing of Distal Regulatory Elements. Molecular Therapy. 23. S192–S193.
8.
Ousterout, David G., Ami M. Kabadi, Pratiksha I. Thakore, et al.. (2014). Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger Nucleases. Molecular Therapy. 23(3). 523–532. 85 indexed citations
9.
Chakraborty, Syandan, HaYeun Ji, Ami M. Kabadi, et al.. (2014). A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Specification. Stem Cell Reports. 3(6). 940–947. 170 indexed citations
10.
Kabadi, Ami M., David G. Ousterout, Isaac B. Hilton, & Charles A. Gersbach. (2014). Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Research. 42(19). e147–e147. 264 indexed citations
11.
Kabadi, Ami M. & Charles A. Gersbach. (2014). Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression. Methods. 69(2). 188–197. 36 indexed citations
12.
Kabadi, Ami M., Pratiksha I. Thakore, Christopher M. Vockley, et al.. (2014). Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain. ACS Synthetic Biology. 4(6). 689–699. 34 indexed citations
13.
Ousterout, David G., Pablo Pérez‐Piñera, Pratiksha I. Thakore, et al.. (2013). Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients. Molecular Therapy. 21(9). 1718–1726. 139 indexed citations
14.
Pérez‐Piñera, Pablo, D. Dewran Koçak, Christopher M. Vockley, et al.. (2013). RNA-guided gene activation by CRISPR-Cas9–based transcription factors. Nature Methods. 10(10). 973–976. 1005 indexed citations breakdown →
15.
Gooden, David M., Dawn M. Z. Schmidt, Julie A. Pollock, Ami M. Kabadi, & Dewey G. McCafferty. (2008). Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B. Bioorganic & Medicinal Chemistry Letters. 18(10). 3047–3051. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zairan Liu Breakdown of academic impact, for papers by Samira Kiani Breakdown of academic impact, for papers by Marcelle Tuttle Breakdown of academic impact, for papers by Isaac B. Hilton Breakdown of academic impact, for papers by Kendell Clement Breakdown of academic impact, for papers by Nicolas Wyvekens Breakdown of academic impact, for papers by Sarah J. Hinkley Breakdown of academic impact, for papers by Suhani Vora Breakdown of academic impact, for papers by Daniel P. Dever Breakdown of academic impact, for papers by Michael C. Bassik
Rankless by CCL
2026